Horizon Therapeutics PLC (HZNP) stock has gained 43.64% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives HZNP stock a score of 74 out of a possible 100. That rank is influenced by a short-term technical score of 88. HZNP's rank also includes a fundamental score of 68. In addition to the average rating from Wall Street analysts, HZNP stock has a mean target price of $134.10. This means analysts expect the stock to add 30.63% over the next 12 months. The long-term technical score for HZNP is 66.
Horizon Therapeutics PLC (HZNP) Stock Is Lower By -2.65% This Week: Buy, Hold, or Sell?
HZNP has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on HZNP!